DiaMedica Therapeutics Market Sentiment - Benzinga

DiaMedica Therapeutics Inc

DMACNASDAQ

Trade with Public

Trade with Public

$6.39

-0.36-5.33%

At close: Aug 28, 5:00 PM EST

$6.75

0.365.63%

After Hours: Aug 27, 4:00 PM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

DiaMedica Therapeutics Market Sentiment

Market sentiment signals for DiaMedica Therapeutics (DMAC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 14.8% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

—

0 calls · 1 puts

Avg Consensus PT

$13

+87.7%

Highest Price Target

$25

+270.4%

Cantor Fitzgerald

Lowest Price Target

$6

-11.1%

Oppenheimer

Short Interest

14.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 11, 2026	HC Wainwright & Co.	Matthew Caufield—	+77.8%	$12 → $12	Maintained	Buy
Nov 14, 2025	Cantor Fitzgerald	Josh Schimmer—	+270.4%	$25	Initiate	Overweight
Aug 15, 2025	HC Wainwright & Co.	Matthew Caufield—	+77.8%	$12 → $12	Maintained	Buy
Jul 18, 2025	Craig-Hallum	Chase Knickerbocker—	+63.0%	$8 → $11	Maintained	Buy
Jul 18, 2025	Lake Street	Thomas Flaten—	+107.4%	$11 → $14	Maintained	Buy
Jul 18, 2025	HC Wainwright & Co.	Matthew Caufield—	+77.8%	$10 → $12	Maintained	Buy
May 29, 2025	HC Wainwright & Co.	Matthew Caufield—	+48.1%	$10 → $10	Maintained	Buy
Mar 19, 2025	HC Wainwright & Co.	Matthew Caufield—	+48.1%	$7 → $10	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Matthew Caufield—	+3.7%	$7 → $7	Maintained	Buy
Oct 10, 2024	HC Wainwright & Co.	Matthew Caufield—	+3.7%	$7 → $7	Maintained	Buy
Oct 7, 2024	HC Wainwright & Co.	Matthew Caufield—	+3.7%	$7	Initiate	Buy
Aug 16, 2024	Oppenheimer	Francois Brisebois—	-11.1%	$6 → $6	Maintained	Outperform
Apr 24, 2024	Craig-Hallum	Alexander Nowak—	+18.5%	$8	Assumes	Buy
Mar 21, 2024	Craig-Hallum	Alexander Nowak—	+18.5%	$11 → $8	Maintained	Buy
Mar 21, 2024	Oppenheimer	Francois Brisebois—	-11.1%	$7 → $6	Maintained	Outperform

More with Benzinga EdgeGet Access

Insider & Market Activity News

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Stocks That Hit 52-Week Lows On Monday

On Monday, 160 companies hit new 52-week lows.

Benzinga Insights

3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More

U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Stocks That Hit 52-Week Lows On Thursday

Thursday's session saw 49 companies set new 52-week lows.

Benzinga Insights

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Stocks That Hit 52-Week Lows On Wednesday

During Wednesday's morning trading, 400 companies set new 52-week lows.

Benzinga Insights